LUNG
Pulmonx Corp
NASDAQ: LUNG · HEALTHCARE · MEDICAL DEVICES
$1.28
+6.67% today
Updated 2026-04-30
Market cap
$54.06M
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$1 – $5
Volume
0.6M
Pulmonx Corp (LUNG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-811780.00 | $-1.34M | $-2.56M | $-2.03M | $-4.64M | $-18.39M | $-20.77M | $-30.63M | $-41.43M | $-45.14M | $-37.61M | $-31.54M | $-32.45M |
| Capital expenditures | $1014.00 | $63150.00 | $164489.00 | $27195.00 | $27195.00 | $316000.00 | $720000.00 | $911000.00 | $3.67M | $1.32M | $807000.00 | $1.45M | $452000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | $366000.00 | $364000.00 | $3.20M | $10.53M | $16.45M | $22.10M | $22.95M | $21.23M |
| Free cash flow | $-812794.00 | $-1.40M | $-2.72M | $-2.06M | $-4.66M | $-18.71M | $-21.48M | $-31.54M | $-45.10M | $-46.45M | $-38.42M | $-32.98M | $-32.90M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $46.19M | $21000.00 | — | — | $21.40M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $216.89M | $-83.19M | $-46.89M | — | — | — |